Polycystic Ovary Syndrome

Women with polycystic ovary syndrome, obesity and irregular menses were more than twice as likely to experience spontaneous ovulation during the year after undergoing bariatric surgery compared with medical therapy, researchers reported.

SAN FRANCISCO — An updated evidence-based guideline for the assessment and management of polycystic ovary syndrome includes new recommendations for a timelier diagnosis and evidence that firmly supports PCOS is a risk factor for CVD.

Women reporting irregular menstrual cycles with or without diagnosed polycystic ovary syndrome are more likely to have cardiometabolic conditions such as diabetes and hypertension, according to new data from the Apple Women’s Health Study.

NEW ORLEANS —The rise in use of diabetes medications and continuous glucose monitoring had led to new challenges for treating pregnant women with diabetes.

Acrochordons, also known as skin tags or fibroepithelial polyps, are correlated with metabolic disease and obesity in pediatric patients, according to a study.

Childhood adiposity could predict future polycystic ovary syndrome in girls, according to a study published in Pediatrics.

The FDA is allowing Dexcom Stelo to market and sell a continuous glucose monitor to patients without a prescription. The Dexcom Stelo Glucose Biosensor System will be the first over-the-counter CGM on the market.

Findings on the use of inositol for managing polycystic ovary syndrome are inconclusive, with results varying based on therapy, trial design and outcomes reported, according to a systematic review and meta-analysis.

Polycystic ovary syndrome was associated with increased risk for CVD in women, and while incidence varies, its prevalence worldwide increased since 1990, researchers reported.

Women with polycystic ovary syndrome were at a more than eightfold risk for attempting suicide, with young adults particularly susceptible to risk, according to a study published in Annals of Internal Medicine.